Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer

Lung Cancer

Volumn 100, Issue , 2016, Pages 90-95

  Jeppesen, Stefan S ^a,b   Hansen, Niels Chr G ^a   Schytte, Tine ^a   Nielsen, Morten ^a   Hansen, Olfred ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

COPD; early stage lung cancer; non small cell lung cancer; SBRT; survival

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL; CANCER STAGING; COMPLICATION; DENMARK; EPIDEMIOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOSURGERY; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DENMARK; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOSURGERY; SURVIVAL RATE;

EID: 84982253588     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.08.006     Document Type: Article

References (24)

1. [1] Engholm, G., Ferlay, J., Christensen, N., Bray, F., Gjerstorff, M.L., Klint, A., Kotlum, J.E., Olafsdottir, E., Pukkala, E., Storm, H.H., NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 49:5 (2010), 725–736, 10.3109/02841861003782017.
2. [2] Howington, J.A., Blum, M.G., Chang, A.C., Balekian, A.A., Murthy, S.C., Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:Suppl. 5 (2013), e278S–e313S, 10.1378/chest.12-2359.
3. [3] Scorsetti, M., Navarria, P., Facoetti, A., Lattuada, P., Urso, G., Mirandola, A., Ferraroli, G.M., Alloisio, M., Ravasi, G., Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer. Anticancer Res. 27:5b (2007), 3615–3619.
4. [4] Kopek, N., Paludan, M., Petersen, J., Hansen, A.T., Grau, C., Høyer, M., Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Radiother. Oncol. 93:3 (2009), 402–407, 10.1016/j.radonc.2009.06.002.
5. [5] Blot, W.J., Cohen, S.S., Aldrich, M., McLaughlin, J.K., Hargreaves, M.K., Signorello, L.B., Lung cancer risk among smokers of menthol cigarettes. J. Natl. Cancer Inst. 103:10 (2011), 810–816, 10.1093/jnci/djr102.
6. [6] Kristiansen, C., Schytte, T., Hansen, K.H., Holtved, E., Hansen, O., Trends in lung cancer in elderly in Denmark 1980–2012. Acta Oncol. 55:Suppl. 1 (2016), 46–51, 10.3109/0284186x.2015.1114676.
7. [7] Loganathan, R.S., Stover, D.E., Shi, W., Venkatraman, E., Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 129:5 (2006), 1305–1312, 10.1378/chest.129.5.1305.
8. [8] Mannino, D.M., Buist, A.S., Global burden of COPD: risk factors, prevalence, and future trends. Lancet (London, England) 370:9589 (2007), 765–773, 10.1016/s0140-6736(07)61380-4.
9. [9] Lokke, A., Lange, P., Scharling, H., Fabricius, P., Vestbo, J., COPD: a 25 year follow up study of the general population. Thorax 61:11 (2006), 935–939, 10.1136/thx.2006.062802.
10. [10] Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M., Stockley, R.A., Sin, D.D., Rodriguez-Roisin, R., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187:4 (2013), 347–365, 10.1164/rccm.201204-0596PP.
11. [11] Mannino, D.M., Buist, A.S., Petty, T.L., Enright, P.L., Redd, S.C., Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58:5 (2003), 388–393.
12. [12] Palma, D., Lagerwaard, F., Rodrigues, G., Haasbeek, C., Senan, S., Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int. J. Radiat. Oncol. Biol. Phys. 82:3 (2012), 1149–1156, 10.1016/j.ijrobp.2011.03.005.
13. [13] Quanjer P, D.A., Van Zoramen, B., Standardised lung function testing. report of the working party for the european community for coal and steel. Bull. Eur. Physiopathol. Respir. 19:Suppl. 5 (1983), 1–95.
14. [14] Jeppesen, S.S., Schytte, T., Jensen, H.R., Brink, C., Hansen, O., Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol. 52:7 (2013), 1552–1558, 10.3109/0284186x.2013.813635.
15. [15] Lange, P., Marott, J.L., Vestbo, J., Olsen, K.R., Ingebrigtsen, T.S., Dahl, M., Nordestgaard, B.G., Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am. J. Respir. Crit. Care Med. 186:10 (2012), 975–981, 10.1164/rccm.201207-1299OC.
16. [16] Zhai, R., Yu, X., Shafer, A., Wain, J.C., Christiani, D.C., The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest 145:2 (2014), 346–353, 10.1378/chest.13-1176.
17. [17] Louie, A.V., Rodrigues, G., Hannouf, M., Lagerwaard, F., Palma, D., Zaric, G.S., Haasbeek, C., Senan, S., Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis. Radiother. Oncol. 99:2 (2011), 161–165, 10.1016/j.radonc.2011.04.005.
18. [18] Quanjer, P.H., Stanojevic, S., Cole, T.J., Baur, X., Hall, G.L., Culver, B.H., Enright, P.L., Hankinson, J.L., Ip, M.S., Zheng, J., Stocks, J., Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 40:6 (2012), 1324–1343, 10.1183/09031936.00080312.
19. [19] Iachina, M., Jakobsen, E., Moller, H., Luchtenborg, M., Mellemgaard, A., Krasnik, M., Green, A., The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung 193:2 (2015), 291–297, 10.1007/s00408-014-9675-5.
20. [20] van der Voort van Zyp, N.C., van der Holt, B., van Klaveren, R.J., Pattynama, P., Maat, A., Nuyttens, J.J., Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer 69:3 (2010), 296–301, 10.1016/j.lungcan.2009.12.008.
21. [21] Sandhu, A.P., Lau, S.K.M., Rahn, D., Nath, S.K., Kim, D., Song, W.Y., Gulaya, S., Fuster, M.M., Bazhenova, L., Mundt, A.J., Stereotactic body radiation therapy in octogenarians with stage I lung cancer. Clin. Lung Cancer 15:2 (2014), 131–135, 10.1016/j.cllc.2013.08.007.
22. [22] Haasbeek, C.J.A., Lagerwaard, F.J., Antonisse, M.E., Slotman, B.J., Senan, S., Stage I nonsmall cell lung cancer in patients aged ≥75 years. Cancer 116:2 (2010), 406–414, 10.1002/cncr.24≥759.
23. [23] Ricardi, U., Badellino, S., Filippi, A.R., Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiat. Oncol. J. 33:2 (2015), 57–65, 10.3857/roj.2015.33.2.57.
24. [24] Koshy, M., Malik, R., Mahmood, U., Husain, Z., Sher, D.J., Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother. Oncol. 114:2 (2015), 148–154, 10.1016/j.radonc.2014.12.004.